|
Education
Honors and Rewards
Publications
Experience
Research/Multi-Center Studies
Presentations
EDUCATION:
MEDICAL Albany Med, Albany NY, Retina Fellowship July 2002-2003
University of Texas, Houston TX, Retina Fellowship July 2001-2002.
Hahnemann University Hospital, Philadelphia PA, Ophthalmology, July 1998-2001 Lic. #MT-044124-T.
Winthrop University Hospital, Mineola NY, Internal Medicine, completed June 1998 Lic. #210696-1.
SUNY Health Science Center at Syracuse NY, M.D., June 1997.
OPTOMETRY SUNY College of Optometry, New York, NY, O.D., June 1989; Lic. # TOO4994.
COLLEGE Brandeis University, A.B., June 1985.
HONORS AND AWARDS:
MEDICAL
Golden Apple Teaching Award 2003
OPTOMETRY
Beta Sigma Kappa Honor Society
National Deans List
COLLEGE
Cum Laude
Hebrew Language Award
PUBLICATIONS:
Naomi S. Falk , Paul M. Beer, Kim Stepien, Pamela Kaw , George B. Peters III
Increased Choroidal Non-perfusion after Combination Therapy with Verteporfin and Intravitreal Triamcinolone Acetonide for Subfoveal Choroidal Neovascularization in Age Related Macular Degeneration
Submitted to Retina for publication
Naomi S. Falk, Paul M. Beer, George B. Peters III. Role of Intravitreal Triamcinolone Acetonide for the Treatment of Postoperative Endophthalmitis
Accepted for publication in Retina
Naomi S. Falk, Sophie J. Bakri, Paul M. Beer, George B. Peters III. Intravitreal Preservative-Free Triamcinolone Acetonide for the treatment of Macular Edema. Accepted for publication in Eye
Paul M. Beer, Sophie J. Bakri, Naomi S. Falk, George B. Peters III. Verteporfin Photodynamic Therapy for Macular Edema Due to Radiation Retinopathy. To be submitted for publication Ophthalmology
Jonathan A. Nickel, Sophie J. Bakri, Paul M. Beer,
Naomi S. Falk, George B. Peters III. Verteporphin Photodynamic Therapy for Neovascular Age Related Macular Degeneration Associated with Subretinal Hemorrhage. To be submitted for publication Ophthalmology
“The Primary Care Optometric Evaluation of the Traumatic Brain Injury Patient.” Falk NS, Aksionoff EB. J Am Optom Assoc. 1992; 63:547-53.
“Differential Diagnosis of Perceptual Deficits in Brain Injury Patients.” Aksionoff EB, Falk NS. J Am Optom Assoc. 1992; 63:554-8.
“Optometric Therapy for Left Brain Injured Patient.” Aksionoff EB, Falk NS . J Am Optom Assoc. 1992; 63:564-8.
“Drug Induced Effects on Secretion of the Rat Lacrimal Gland.” Poster Session, American Academy of Optometry;Toronto. Canada; December 1986.
EXPERIENCE:
CLINICAL:
Assistant Clinical Professor, Albany Medical Center with surgical privileges at Albany Medical Center, Childs Hospital and Albany Memorial Hospital
July 2003- present.
Practicing in full scope private retina practice including management of medical and surgical disease, iodine plaque therapy for choroidal melanoma, plus participation in multi-center clinical trials for macular degeneration, diabetes and macular edema.
July 2002-June 2003
Vitreoretinal Fellow, Albany Medical Center.
July 2001-June 2002
Vitreoretinal Fellow, University of Texas.
July 2000 – June 2001
Chief Resident, Hahnemann University Hospital.
July 1998 –June 2001
Ophthalmology Resident, Hahnemann University Hospital.
July 1997 – June 1998
Medical Intern, Winthrop University Hospital.
July 1990 – June 1993
Assistant Clinical Professor, SUNY College of Optometry.
June 1990 - June 1993
Staff Optometrist and Clinical Instructor, Veterans Hospital, Northport, NY.
July 1989 – June 1990
Optometric Resident, Veterans Hospital, Northport, NY. Full scope clinical program includes Primary care, Pathology, Low Vision, Contact lenses, Vision Therapy and Head Trauma rehabilitation.
RESEARCH/MULTI-CENTER STUDIES:
Horizon extension study for Marina and Anchor - 2005-present
Sub-Investigator
Pegaptanib Sodium [Macugen]; EOP1010 - 2003-2005
Compassionate trial
Intravitreal Triamcinolone for Diabetic - 2004-2007
Macular Edema Study. Diabetic Retinopathy
Clinical Research Study 1-B, National Eye Institute
Study Protocol Planning Committee
Pegaptanib Sodium [EYE001; Macugen] - 2003-2005
versus PDT with Visudyne; EOP 1008
Sub-Investigator
Pilot Laser Photocoagulation for Diabetic- 2003-2005
Macular Edema Study. Diabetic Retinopathy
Clinical Research Study 1-A, National Eye Institute
Sub-Investigator.
Efficacy and Safety of rhuFab V2 Compared to -2003-2005
Verteporfin photodynamic Therapy in Subjects with
Predominantly Classic Subfoveal Neovascular Age-Related
Macular Degeneration
ANCHOR Sub-Investigator
Minimally classic/occult trial of the Anti-VEGF - 2003-2005
Antibody Rhufab in the treatment of
Neovascular Age related Macular Degeneration
MARINA Sub-Investigator
Prospective and Retrospective Demographic Study of Treatment Regiments for Ocular Trauma, June 1993 – August 1993.
Laboratory Evaluation of Peroxidase Secretion, Stimulation of Potassium and Phosphate Production in the Rat Lacrimal Gland (Advisor: John Picarelli, PhD.), 1986 – 1988.
Experiments evaluating deposits occurring on soft contact lenses (Advisor: Jerold Rapp, PhD.), 1985 – 1986.
PRESENTATIONS:
Naomi Falk, Paul Beer, George Peters III. Role of Intravitreal triamcinolone Acetonide for the treatment of postoperative endophthalmitis.
Annual meeting of the American Society of Retina Specialists, Montreal, Canada July 2005
Naomi S. Falk , Paul M. Beer, Kim Stepien, Pamela Kaw , George B. Peters III
Increased Choroidal Non-perfusion after Combination Therapy with Verteporfin and Intravitreal Triamcinolone Acetonide for Subfoveal Choroidal Neovascularization in Age Related Macular Degeneration
Poster session at annual meeting of the American Society of Retina Specialists, Montreal, Canada July 2005
Kimberly E Stepien, Paul M Beer, George Peters III, Naomi Falk. Optical coherence tomography findings in the macula of patients undergoing pneumatic retinopexy for rhegmatogenous retina detachment.
Poster session at annual meeting of the American Society of Retina Specialists, Montreal, Canada July 2005
Paul M. Beer, Sophie J. Bakri, Naomi S. Falk, George B. Peters III. Verteporfin Photodynamic Therapy for Macular Edema Due to Radiation Retinopathy. 21 st Annual Meeting of the American Society of Retina Specialists, N.Y.C. NY August 20, 2003
Naomi S. Falk, Sophie J. Bakri, Paul M. Beer, George B. Peters III. Intravitreal Preservative-Free Triamcinolone Acetonide for the treatment of Macular Edema. 21 st Annual Meeting of the American Society of Retina Specialists, N.Y.C. NY August 20, 2003
Jonathan A. Nickel, Sophie J. Bakri, Paul M. Beer,
Naomi S. Falk, George B. Peters III. Verteporphin Photodynamic Therapy for Neovascular Age Related Macular Degeneration Associated with Subretinal Hemorrhage. 21 st Annual Meeting of the American Society of Retina Specialists, N.Y.C. NY August 18, 2003
Falk, N. Anti-VEGF compounds for the Treatment of Macular Degeneration
An Update for Eye Care Providers.
Guest Lecturer: The Johns Hopkins University: Albany Institute of Art.
Albany , N.Y. , June 18, 2003
Falk, N Developments in Macular Degeneration
Glens Falls Primary Eye Care Conference
Glens Falls , N.Y. , May 5, 2003
Falk, Naomi : What’s New in Macular Degeneration Therapy? Monitoring – The Standard of Care. Second Annual Ocular Immunology and Uveitis Foundation Physician Education Conference: “What’s New In Posterior Segment Disorders”, The Marriott Cambridge, Cambridge, MA October 20, 2007.
Falk, Naomi : What’s New in Retinal Vascular Disease? Arterial Occlusion Treatment Advances. Second Annual Ocular Immunology and Uveitis Foundation Physician Education Conference: “What’s New In Posterior Segment Disorders”, The Marriott Cambridge, Cambridge, MA October 20, 2007.
|
